148 related articles for article (PubMed ID: 6838497)
1. An increase in high-molecular weight renin substrate associated with estrogenic hypertension.
Shionoiri H; Eggena P; Barrett JD; Thananopavarn C; Golub MS; Eggena Z; Nakamura R; Judd HL; Sambhi MP
Biochem Med; 1983 Feb; 29(1):14-22. PubMed ID: 6838497
[TBL] [Abstract][Full Text] [Related]
2. Oral contraceptives--induced hypertension--nine years later.
Laragh JH
Am J Obstet Gynecol; 1976 Sep; 126(1):141-7. PubMed ID: 961741
[TBL] [Abstract][Full Text] [Related]
3. Drug-induced hypertension: pathogenesis and management.
Stokes GS
Drugs; 1976; 12(3):222-30. PubMed ID: 185040
[TBL] [Abstract][Full Text] [Related]
4. Differences in the kinetic rate constants of normal and high molecular weight renin substrate from term pregnancy human plasma.
Shionoiri H; Gotoh E; Kaneko Y; Eggena P; Sambhi MP
Endocrinol Jpn; 1983 Dec; 30(6):731-6. PubMed ID: 6373244
[TBL] [Abstract][Full Text] [Related]
5. Chromatographic separation of multiple renin substrates in women: effect of pregnancy and oral contraceptives.
Gordon DB; Sachin IN
Proc Soc Exp Biol Med; 1977 Dec; 156(3):461-4. PubMed ID: 594076
[TBL] [Abstract][Full Text] [Related]
6. Active and inactive renin in pregnancy and in women on estrogen-containing oral contraceptives.
Hayashi M; Saruta T; Nakamura R; Saito I; Kondo K; Kato E
Gynecol Obstet Invest; 1979; 10(5):246-53. PubMed ID: 395034
[TBL] [Abstract][Full Text] [Related]
7. High molecular weight angiotensinogen levels in hypertensive pregnant women.
Tewksbury DA; Dart RA
Hypertension; 1982; 4(5):729-34. PubMed ID: 7106939
[TBL] [Abstract][Full Text] [Related]
8. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
[TBL] [Abstract][Full Text] [Related]
9. Multiple forms of human plasma renin substrate.
Eggena P; Hidaka H; Barrett JD; Sambhi MP
J Clin Invest; 1978 Aug; 62(2):367-72. PubMed ID: 670398
[TBL] [Abstract][Full Text] [Related]
10. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.
Oelkers W; Foidart JM; Dombrovicz N; Welter A; Heithecker R
J Clin Endocrinol Metab; 1995 Jun; 80(6):1816-21. PubMed ID: 7775629
[TBL] [Abstract][Full Text] [Related]
11. Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones.
Adlercreutz H; Pulkkinen MO; Hämäläinen EK; Korpela JT
J Steroid Biochem; 1984 Jan; 20(1):217-29. PubMed ID: 6231418
[TBL] [Abstract][Full Text] [Related]
12. Oestrogens and hypertension.
Roberts JM
Clin Endocrinol Metab; 1981 Nov; 10(3):489-512. PubMed ID: 7047019
[TBL] [Abstract][Full Text] [Related]
13. [Oral contraceptives, hypertension and nephrosclerosis].
Girndt J
Fortschr Med; 1978 Feb; 96(7):327-32. PubMed ID: 627380
[TBL] [Abstract][Full Text] [Related]
14. [Oral contraceptives and arterial hypertension].
Pinheiro RL; da Costa JN
Rev Port Cardiol; 1988; 7(3):333-43. PubMed ID: 3078732
[TBL] [Abstract][Full Text] [Related]
15. Effect of desogestrel-containing oral contraceptives on vascular reactivity and catecholamine levels.
Arangino S; Cagnacci A; Angiolucci M; Longu G; Melis GB; Volpe A
Contraception; 1998 Nov; 58(5):289-93. PubMed ID: 9883384
[TBL] [Abstract][Full Text] [Related]
16. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
[TBL] [Abstract][Full Text] [Related]
17. The effect of posture and saline loading on plasma renin activity and aldosterone concentration in pregnant, non-pregnant and estrogen-treated women.
Weinberger MH; Kramer NJ; Grim CE; Petersen LP
J Clin Endocrinol Metab; 1977 Jan; 44(1):69-77. PubMed ID: 833263
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind study of two combined oral contraceptives containing the same progestogen, but different estrogens. World Health Organization Task Force on Oral Contraception.
Contraception; 1980 May; 21(5):445-59. PubMed ID: 7428356
[TBL] [Abstract][Full Text] [Related]
19. A direct radioimmunoassay for human renin substrate and identification of multiple substrate types in plasma.
Eggena P; Barrett JD; Hidaka H; Chu CL; Thananopavarn C; Golub MS; Sambhi MP
Circ Res; 1977 Oct; 41(4 Suppl 2):34-7. PubMed ID: 902368
[TBL] [Abstract][Full Text] [Related]
20. Comparative study of the effect of oral contraceptives containing 50 microgram of estrogen and those containing 20 microgram of estrogen on adrenal cortical function.
Amin ES; El-Sayed MM; El-Gamel BA; Nayel SA
Am J Obstet Gynecol; 1980 Aug; 137(7):831-3. PubMed ID: 7405974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
